{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:09:03Z","timestamp":1778638143345,"version":"3.51.4"},"reference-count":40,"publisher":"American Society for Microbiology","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Knowledge of the sequences and structures of proteins produced by microbial pathogens is continuously increasing. Besides offering the possibility of unraveling the mechanisms of pathogenesis at the molecular level, structural information provides new tools for vaccine development, such as the opportunity to improve viral and bacterial vaccine candidates by rational design. Structure-based rational design of antigens can optimize the epitope repertoire in terms of accessibility, stability, and variability. In the present study, we used epitope mapping information on the well-characterized antigen of<jats:named-content content-type=\"genus-species\">Neisseria meningitidis<\/jats:named-content>factor H binding protein (fHbp) to engineer its gonococcal homologue, Ghfp. Meningococcal fHbp is typically classified in three distinct antigenic variants. We introduced epitopes of fHbp variant 1 onto the surface of Ghfp, which is naturally able to protect against meningococcal strains expressing fHbp of variants 2 and 3. Heterologous epitopes were successfully transplanted, as engineered Ghfp induced functional antibodies against all three fHbp variants. These results confirm that structural vaccinology represents a successful strategy for modulating immune responses, and it is a powerful tool for investigating the extension and localization of immunodominant epitopes.<\/jats:p>","DOI":"10.1128\/cvi.00794-14","type":"journal-article","created":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T02:01:01Z","timestamp":1430964061000},"page":"769-777","source":"Crossref","is-referenced-by-count":8,"title":["Molecular Engineering of Ghfp, the Gonococcal Orthologue of Neisseria meningitidis Factor H Binding Protein"],"prefix":"10.1128","volume":"22","author":[{"given":"Valentina","family":"Rippa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Santini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Lo Surdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Cantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Veggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Iannello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brunella","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ferlicca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiliano","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Pallaoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Aric\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Banci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariagrazia","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Scarselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","published-online":{"date-parts":[[2015,5,6]]},"reference":[{"key":"key20180919073807_B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1478-7954-11-17","article-title":"Global epidemiology of invasive meningococcal disease","volume":"11","year":"2013","journal-title":"Popul Health Metr"},{"key":"key20180919073807_B2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1517\/14656566.5.4.855","article-title":"Meningococcal conjugate vaccines","volume":"5","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"key20180919073807_B3","doi-asserted-by":"publisher","first-page":"B18","DOI":"10.1016\/j.vaccine.2012.01.062","article-title":"Meningococcal vaccine development\u2013from glycoconjugates against MenACWY to proteins against MenB\u2013potential for broad protection against meningococcal disease","volume":"30","year":"2012","journal-title":"Vaccine"},{"key":"key20180919073807_B4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/INF.0b013e31826327e4","article-title":"Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18\u201336 months: a phase 1 randomized-controlled clinical trial","volume":"31","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key20180919073807_B5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/INF.0b013e31827b0d24","article-title":"A randomized, controlled, phase 1\/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents","volume":"32","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"key20180919073807_B6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2217\/imt.14.11","article-title":"Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention","volume":"6","year":"2014","journal-title":"Immunotherapy"},{"key":"key20180919073807_B7","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1128\/CVI.00055-11","article-title":"Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein","volume":"18","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key20180919073807_B8","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","year":"2003","journal-title":"J Exp Med"},{"key":"key20180919073807_B9","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","year":"2004","journal-title":"Infect Immun"},{"key":"key20180919073807_B10","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1016\/j.vaccine.2012.07.065","article-title":"A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial","volume":"30","year":"2012","journal-title":"Vaccine"},{"key":"key20180919073807_B11","doi-asserted-by":"publisher","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20180919073807_B12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","year":"2006","journal-title":"J Immunol"},{"key":"key20180919073807_B13","doi-asserted-by":"publisher","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","article-title":"Functional significance of factor H binding to Neisseria meningitidis","volume":"176","year":"2006","journal-title":"J Immunol"},{"key":"key20180919073807_B14","doi-asserted-by":"publisher","first-page":"91ra62","DOI":"10.1126\/scitranslmed.3002234","article-title":"Rational design of a meningococcal antigen inducing broad protective immunity","volume":"3","year":"2011","journal-title":"Sci Transl Med"},{"key":"key20180919073807_B15","doi-asserted-by":"publisher","first-page":"e1003528","DOI":"10.1371\/journal.ppat.1003528","article-title":"Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor H binding protein","volume":"9","year":"2013","journal-title":"PLoS Pathog"},{"key":"key20180919073807_B16","doi-asserted-by":"publisher","first-page":"9384","DOI":"10.1021\/bi301161w","article-title":"The factor H binding protein of Neisseria meningitidis interacts with xenosiderophores in vitro","volume":"51","year":"2012","journal-title":"Biochemistry"},{"key":"key20180919073807_B17","doi-asserted-by":"publisher","first-page":"e1002981","DOI":"10.1371\/journal.ppat.1002981","article-title":"Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules","volume":"8","year":"2012","journal-title":"PLoS Pathog"},{"key":"key20180919073807_B18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S1744309111006154","article-title":"Structure of the uncomplexed Neisseria meningitidis factor H binding protein fHbp (rLP2086)","volume":"67","year":"2011","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"key20180919073807_B19","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nature07769","article-title":"Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates","volume":"458","year":"2009","journal-title":"Nature"},{"key":"key20180919073807_B20","doi-asserted-by":"publisher","first-page":"7220","DOI":"10.1074\/jbc.M508595200","article-title":"Solution structure of the immunodominant domain of protective antigen GNA1870 of Neisseria meningitidis","volume":"281","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180919073807_B21","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1128\/IAI.00367-08","article-title":"Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor H binding protein","volume":"76","year":"2008","journal-title":"Infect Immun"},{"key":"key20180919073807_B22","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1128\/IAI.73.2.1151-1160.2005","article-title":"The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies","volume":"73","year":"2005","journal-title":"Infect Immun"},{"key":"key20180919073807_B23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jmb.2008.12.005","article-title":"Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis","volume":"386","year":"2009","journal-title":"J Mol Biol"},{"key":"key20180919073807_B24","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1096\/fj.13-239012","article-title":"Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties","volume":"28","year":"2014","journal-title":"FASEB J"},{"key":"key20180919073807_B25","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1073\/pnas.1222845110","article-title":"Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen","volume":"110","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20180919073807_B26","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.4049\/jimmunol.172.9.5606","article-title":"Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine","volume":"172","year":"2004","journal-title":"J Immunol"},{"key":"key20180919073807_B27","doi-asserted-by":"publisher","first-page":"9022","DOI":"10.1074\/jbc.C800214200","article-title":"Solution structure of the factor H binding protein, a survival factor and protective antigen of Neisseria meningitidis","volume":"284","year":"2009","journal-title":"J Biol Chem"},{"key":"key20180919073807_B28","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ab.2005.09.034","article-title":"Analyzing a kinetic titration series using affinity biosensors","volume":"349","year":"2006","journal-title":"Anal Biochem"},{"key":"key20180919073807_B29","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1128\/CDLI.12.8.970-976.2005","article-title":"Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup B, strain 44\/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine","volume":"12","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"key20180919073807_B30","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment","volume":"13","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key20180919073807_B31","doi-asserted-by":"publisher","first-page":"e65043","DOI":"10.1371\/journal.pone.0065043","article-title":"An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"key20180919073807_B32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1073\/pnas.93.1.7","article-title":"Interactions of protein antigens with antibodies","volume":"93","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20180919073807_B33","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1016\/j.molimm.2007.10.016","article-title":"Computational characterization of B-cell epitopes","volume":"45","year":"2008","journal-title":"Mol Immunol"},{"key":"key20180919073807_B34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/prot.10085","article-title":"Dissecting protein-protein recognition sites","volume":"47","year":"2002","journal-title":"Proteins"},{"key":"key20180919073807_B35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1209368","article-title":"Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold","volume":"334","year":"2011","journal-title":"Science"},{"key":"key20180919073807_B36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jmb.2011.10.003","article-title":"Computational design of high-affinity epitope scaffolds by backbone grafting of a linear epitope","volume":"415","year":"2012","journal-title":"J Mol Biol"},{"key":"key20180919073807_B37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jmb.2010.09.061","article-title":"Computational protein design using flexible backbone remodeling and resurfacing: case studies in structure-based antigen design","volume":"405","year":"2011","journal-title":"J Mol Biol"},{"key":"key20180919073807_B38","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1128\/IAI.00891-10","article-title":"Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies","volume":"79","year":"2011","journal-title":"Infect Immun"},{"key":"key20180919073807_B39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0968-0004(99)01540-6","article-title":"NPS@: network protein sequence analysis","volume":"25","year":"2000","journal-title":"Trends Biochem Sci"},{"key":"key20180919073807_B40","doi-asserted-by":"publisher","first-page":"W465","DOI":"10.1093\/nar\/gkn180","article-title":"Phylogeny.fr: robust phylogenetic analysis for the non-specialist","volume":"36","year":"2008","journal-title":"Nucleic Acids Res"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00794-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T15:02:59Z","timestamp":1589382179000},"score":1,"resource":{"primary":{"URL":"https:\/\/cvi.asm.org\/content\/22\/7\/769"}},"subtitle":[],"editor":[{"given":"M. F.","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,6]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,6,23]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1128\/CVI.00794-14"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00794-14","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,6]]}}}